On Capitol Hill: One Day In The Hard Life Of The Genome Project

A routine hearing turns explosive when a critic of the program finds himself under attack by a prominent senator WASHINGTON - On the morning of July 11, in the rear of Room 366 of the Dirksen Senate Office Building, health policy analyst Robert Cook-Degan was pacing anxiously. It was supposed to be a routine hearing, a chance for officials from the government's Human Genome Project to explain to a very sympathetic audience how well two federal agencies - the National Institutes of Health and t

| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share


A routine hearing turns explosive when a critic of the program finds himself under attack by a prominent senator
WASHINGTON - On the morning of July 11, in the rear of Room 366 of the Dirksen Senate Office Building, health policy analyst Robert Cook-Degan was pacing anxiously. It was supposed to be a routine hearing, a chance for officials from the government's Human Genome Project to explain to a very sympathetic audience how well two federal agencies - the National Institutes of Health and the Department of Energy - were working together on this first "big science" project in biology and what technological benefits might flow from mapping and sequencing the 3 billion base pairs that constitute the human genetic code.

But Cook-Degan, a former senior analyst at the congressional Office of Technology Assessment and a consultant to NIH's genome center, sensed trouble. Two of the witnesses - Harvard University ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo